Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The best place for this stock is sbfm stocktwits. Tons of pissed off people with high averages and lots of DD. Ihub and twitter are mostly quiet on sbfm
The July RS Info Statements (PRE 14C and DEF 14C) are no longer posted on the SBFM website or Nasdaq! Is this coincidental and/or mean anything?
https://sunshinebiopharma.com/sec-filings/
https://www.nasdaq.com/market-activity/stocks/sbfm/sec-filings?page=1&rows_per_page=14
Losing money, wondering if they will be profitable down the road
Surely sec will do something
Let’s all hold hands and pray for RNAZ the real New hope for terminally ill cancer patients Novel Lead Therapeutic Candidate, TTX-MC138
Could be
We will see.
Funny face
Getting interesting, .3204 and dropping
I don’t understand any of this anymore.
Why are they relying on Colorado law to exclude shareholders from their decision to effect yet another Reverse Split, when their business HQ is in Ft. Lauderdale, FL?
And why a 1:60, when they only just completed a 1:100? Does the company have NO financial value at all, that these accounting tricks are necessary?
Final comment: it is nauseating when CEO’s don’t reduce their own shares, but just stick it to everybody else.
They should have agreed to be delisted from the NASDAQ, until such time as organic growth earned them a chance to rejoin it. All the verbiage about increasing liquidity, blah blah blah, rings hollow when the are reducing the OS from 24 million to 39 thousands. What a farce! Does he read his own writing?!?
I thought SBFM got caught doing some fishy business with the the last RS and Warrants. Whey would the Nasdaq panel allow another RS vs. delisting SBFM now?
Looks like they will be doing yet another RS after all!!! This really hurts…
Are we om for another RS or can SBFM get back over $1 some other way (see below from the 8K today)?
The last time they did a RS and Warrants seemed a bit shady and the Nasdaq was "concerned" about how they did it.
Item 8.01. Other Events.
On June 28, 2024, Sunshine Biopharma, Inc. (the “Company”) received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”), informing the Company that the Nasdaq Hearings Panel has granted the Company’s request for an exception until August 26, 2024, to regain compliance with Nasdaq’s minimum bid price requirement under Listing Rule 5550(a)(2).
More 🍿 🍿 🍿
🤔
😄
Shareholders post after many r s over a close tine frame
Could this go to dollarsss
Looks like a triple bottom holding for reverse
Up 0.07 maybe reversal ???????
Must be short covering day, taking gains….
Someone posted delist ??????
SBFM needs to unwind all the crap deals they did with Aegis to include giving them back their money and canceling 33 Million shares!
Then, they need to get something done with their drug development pipeline.
I know this is a pipedream, but seems to be the only way to fix their mess.
Friday (6/14/2024) is when SBFM had to respond (in writing) to Nasdaq about the additional listing concerns (aka additional deficiency) related to the "alternate cashless exercise" of the Series A Warrants." SBFM needed to present their views about this concern.
So, did they respond? If so, what was the response? Now we wait for a decision on delisting?
From the 6/7/24 8K filing: "The letter has no immediate effect on the listing of the Company’s common stock. The letter serves as a formal notification that the Nasdaq Hearings Panel (the “Panel”) will consider this matter in their decision regarding the Company’s continued listing on The Nasdaq Capital Market. In that regard, the letter states that the Company should present its views with respect to this additional deficiency to the Panel in writing no later than June 14, 2024."
Followers
|
759
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
113782
|
Created
|
10/27/08
|
Type
|
Free
|
Moderators |
SUNSHINE BIOPHARMA INC
ANTI CANCER DRUGS
ANTI CORONA VIRUS RESEARCH
SBFM Transfer Agent
Corporate Stock Transfer
3200 Cherry Creek Dr. South
Suite 430
Denver, CO 80209
(303) 282 - 4800 p
(303) 282 - 5800 f
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |